Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT01041781 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

313

Enrollment

OTHER

Sponsor class

Stopped DSMB recommendation

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: celecoxib
DRUG: gemcitabine hydrochloride
DRUG: pemetrexed disodium
OTHER: placebo

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]